This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

With Elan Deal, Perrigo Joins Long List of U.S. Corporate Tax Avoiders

ALLEGAN, Mich. (But not for long) ( TheStreet) -- The roots of Perrigo (PRGO - Get Report) go back 126 years. Luther Perrigo, the proprietor of a general store and apple-drying business in western Michigan, had an idea to distribute medicines and other household goods to country stores. From these humble roots, Perrigo grew into a multi-billion dollar business selling over-the-counter and generic medicines, baby formula and nutritional supplements.

Perrigo was an American business success story. That ended Monday, when the company decided to buy Irish drug maker Elan (ELN) for $8.6 billion in order to evade... um, sorry, I mean reduce... its obligation to pay U.S. taxes.

The "new" Perrigo will no longer be headquartered in Allegan, Michigan, home of the "Old Iron Bridge." The company is moving to Dublin, Ireland where Elan is headquartered and companies pay only 12.5 percent corporate income tax.

Of course, Perrigo is not physically moving to Ireland. CEO Joseph Papa and his executives aren't selling their big houses in Michigan -- watched over by cops and firemen paid for with public funding. Their kids will continue to attend school here -- some may even go to U.S. taxpayer-funded public schools! The company's trucks will drive on roads built and maintained by U.S taxpayers.

The only part of Perrigo actually moving to Ireland is its bank account. Last year, Perrigo's effective tax rate was 23 percent. That's not low enough, apparently, so Papa bought Elan and is moving the corporate books to Dublin.

Perrigo is not alone in abandoning the U.S. for an overseas tax haven. Lots of companies are doing it. Apple (AAPL - Get Report) is probably the most famous U.S. income tax avoider, but in healthcare, Pfizer (PFE), Amgen (AMGN - Get Report) and Eli Lilly (LLY - Get Report) have all moved huge chunks of their business to tax-friendly locales.

Perrigo wins, America loses.

--Written by Adam Feuerstein in Boston.



>To contact the writer of this article, click here: Adam Feuerstein.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ELN $0.00 0.00%
AAPL $132.65 1.82%
AMGN $162.38 -3.29%
LLY $70.89 -0.96%
PRGO $188.28 -2.39%

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs